1.
Exploring the Impact of COVID-19 on Migraine-Related Medications Expenditure and Predictors of Economic Burden. Pharm Pract (Granada) [Internet]. 2025 Oct. 8 [cited 2025 Oct. 22];23(3):1-6. Available from: https://pharmacypractice.org/index.php/pp/article/view/3191